PAR PHARMACEUTICAL COMPANIES, INC. Interest Expense
PAR PHARMACEUTICAL COMPANIES, INC. reported Interest Expense of $39.99 million for the 3-month period ending 2015-06-30, per its 10-Q filed 2015-08-06.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2015-08-06
- PAR PHARMACEUTICAL COMPANIES, INC. interest expense for the quarter ending 2015-06-30 was $39.99M, a 45.43% increase year-over-year.
- PAR PHARMACEUTICAL COMPANIES, INC. interest expense for the quarter ending 2015-03-31 was $29.51M, a 15.88% increase year-over-year.
- PAR PHARMACEUTICAL COMPANIES, INC. interest expense for the quarter ending 2014-09-30 was $27.69M, a 18.41% increase year-over-year.
- PAR PHARMACEUTICAL COMPANIES, INC. interest expense for the quarter ending 2014-06-30 was $27.50M, a 16.46% increase year-over-year.
- PAR PHARMACEUTICAL COMPANIES, INC. interest expense for fiscal 2011 was $2.68M, a 7.88% decline from fiscal 2010.
- PAR PHARMACEUTICAL COMPANIES, INC. interest expense for fiscal 2010 was $2.90M, a 63.75% decline from fiscal 2009.
- PAR PHARMACEUTICAL COMPANIES, INC. interest expense for fiscal 2009 was $8.01M.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2015-06-30 | $39.99M 10-Q · filed 2015-08-06 | $69.50M 10-Q · filed 2015-08-06 | ||
| 2015-03-31 | $29.51M 10-Q · filed 2015-05-11 | |||
| 2014-09-30 | $27.69M 10-Q · filed 2014-11-12 | $55.19M derived: sum of 2 quarters · filed 2015-08-06 | $80.66M 10-Q · filed 2014-11-12 | |
| 2014-06-30 | $27.50M 10-Q · filed 2015-08-06 | $52.97M 10-Q · filed 2015-08-06 | ||
| 2014-03-31 | $25.47M 10-Q · filed 2015-05-11 | |||
| 2013-09-30 | $23.39M 10-Q · filed 2014-11-12 | $47.00M derived: sum of 2 quarters · filed 2014-11-12 | $71.03M 10-Q · filed 2014-11-12 | |
| 2013-06-30 | $23.61M 10-Q · filed 2014-08-11 | $47.65M 10-Q · filed 2014-08-11 | ||
| 2013-03-31 | $24.04M 10-Q · filed 2014-05-15 | |||
| 2012-06-30 | $3.07M 10-Q · filed 2012-08-02 | $6.16M 10-Q · filed 2012-08-02 | $8.39M derived: sum of 3 quarters · filed 2012-08-02 | $8.54M derived: sum of 4 quarters · filed 2012-08-02 |
| 2012-03-31 | $3.09M 10-Q · filed 2012-05-08 | $5.32M derived: sum of 2 quarters · filed 2012-05-08 | $5.47M derived: sum of 3 quarters · filed 2012-05-08 | $5.62M derived: sum of 4 quarters · filed 2012-08-02 |
| 2011-12-31 | $2.23M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28 | $2.38M derived: sum of 2 quarters · filed 2012-02-28 | $2.52M derived: sum of 3 quarters · filed 2012-08-02 | $2.68M 10-K · filed 2012-02-28 |
| 2011-09-30 | $150.00K 10-Q · filed 2011-11-02 | $300.00K derived: sum of 2 quarters · filed 2012-08-02 | $451.00K 10-Q · filed 2011-11-02 | $601.00K derived: sum of 4 quarters · filed 2012-08-02 |
| 2011-06-30 | $150.00K 10-Q · filed 2012-08-02 | $301.00K 10-Q · filed 2012-08-02 | $451.00K derived: sum of 3 quarters · filed 2012-08-02 | $1.38M derived: sum of 4 quarters · filed 2012-08-02 |
| 2011-03-31 | $150.00K 10-Q · filed 2012-05-08 | $301.00K derived: sum of 2 quarters · filed 2012-05-08 | $1.23M derived: sum of 3 quarters · filed 2012-05-08 | $2.15M derived: sum of 4 quarters · filed 2012-05-08 |
| 2010-12-31 | $151.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28 | $1.08M derived: sum of 2 quarters · filed 2012-02-28 | $2.00M derived: sum of 3 quarters · filed 2012-02-28 | $2.90M 10-K · filed 2012-02-28 |
| 2010-09-30 | $928.00K 10-Q · filed 2011-11-02 | $1.85M derived: sum of 2 quarters · filed 2011-11-02 | $2.75M 10-Q · filed 2011-11-02 | |
| 2010-06-30 | $918.00K 10-Q · filed 2011-08-03 | $1.83M 10-Q · filed 2011-08-03 | ||
| 2010-03-31 | $908.00K 10-Q/A · filed 2011-05-06 | |||
| 2009-12-31 | $8.01M 10-K · filed 2012-02-28 |